Comparison of Dynamic Distraction Systems in Proximal Interphalangeal Joint Fractures

NCT ID: NCT04470349

Last Updated: 2023-01-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-14

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fractures of the proximal interphalangeal joints continue to pose significant management challenges. Thus the aim of our study is to compare two dynamic finger joint distractors (Litos® and Ligamentotaxor®) in respect to the radiological standard follow-up examination and functional assessments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Proximal Interphalangeal Joint Fracture of the Hand

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LITOS

Patients who received a LITOS dynamic distraction system after 31.12.2017

LITOS

Intervention Type DEVICE

Patients who received a LITOS dynamic distraction system after 31.12.2017

Ligamentotaxor

Patients who received a Ligamentotaxor dynamic distraction system after 31.12.2017

Ligamentotaxor

Intervention Type DEVICE

Patients who received a Ligamentotaxor dynamic distraction system after 31.12.2017

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LITOS

Patients who received a LITOS dynamic distraction system after 31.12.2017

Intervention Type DEVICE

Ligamentotaxor

Patients who received a Ligamentotaxor dynamic distraction system after 31.12.2017

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* proximal interphalangeal fracture treated with external dynamic fixator
* Operative care \<21 days from trauma
* Age between 18 and 90 years.
* Male and female

Exclusion Criteria

\- additional fractures or disabilities of the hand
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Waldfriede Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Markus Bock, MD

Role: PRINCIPAL_INVESTIGATOR

Waldfriede Hospital

Martin Lautenbach, MD

Role: STUDY_CHAIR

Waldfriede Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Waldfriede Hospital

Berlin, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Markus Bock, MD

Role: CONTACT

00493081810201

Matthias Url, MD

Role: CONTACT

00493081810201

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Markus Bock, MD

Role: primary

00493081810201

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020.1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.